A S X A N N O U N C E M E N T ASX : CUV | Nasdaq : CUVL | Börse Frankfurt : UR9 ASX Announcement P A G E 1 O F 2 CLINUVEL Annual Results – Investor Webinar Melbourne / New York – 20 August 2026 – CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) will ...
CLINUVEL Annual Results - Investor Webinar
Filed with ASX ·
6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- Becoming a substantial holder
- CLINUVEL's injectable peptide platform
- Commercial update on vitiligo
- Update - SCENESSE in vitiligo
- CLINUVEL implements strategic reorganisation to refocus on U.S. markets
Later from Clinuvel Pharmaceuticals
- Dividend/Distribution - CUV
- Corporate Governance Statement
- Appendix 4G
- Investor Presentation
- A decade of profitability provides U.S. expansion foundation
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals
